These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27469086)

  • 1. A pill too hard to swallow: how the NHS is limiting access to high priced drugs.
    Gornall J; Hoey A; Ozieranski P
    BMJ; 2016 Jul; 354():i4117. PubMed ID: 27469086
    [No Abstract]   [Full Text] [Related]  

  • 2. High cost of new drugs.
    Mazzucato M
    BMJ; 2016 Jul; 354():i4136. PubMed ID: 27815284
    [No Abstract]   [Full Text] [Related]  

  • 3. Determining the value of drugs--the evolving British experience.
    Faden RR; Chalkidou K
    N Engl J Med; 2011 Apr; 364(14):1289-91. PubMed ID: 21470007
    [No Abstract]   [Full Text] [Related]  

  • 4. Brazil's Fight against Hepatitis C - Universalism, Local Production, and Patents.
    da Fonseca EM; Shadlen K; Bastos FI
    N Engl J Med; 2019 Feb; 380(7):605-607. PubMed ID: 30763192
    [No Abstract]   [Full Text] [Related]  

  • 5. Network. BME service-user led projects.
    Davie E
    Ment Health Today; 2012; ():29. PubMed ID: 22479953
    [No Abstract]   [Full Text] [Related]  

  • 6. Compulsory licences for direct acting antiviral drugs for hepatitis C.
    Cattaneo A; Maciocco G
    BMJ; 2016 Oct; 355():i5314. PubMed ID: 27707734
    [No Abstract]   [Full Text] [Related]  

  • 7. The enigma of value: in search of affordable and accessible health care.
    Szucs TD; Weiss M; Klaus G
    Eur J Health Econ; 2017 Jul; 18(6):667-670. PubMed ID: 27913941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New NICE criteria for drug access.
    Fricker J
    Lancet Oncol; 2017 May; 18(5):576. PubMed ID: 28343973
    [No Abstract]   [Full Text] [Related]  

  • 9. Eliminating innovation: how price controls limit access.
    Ingram J
    J Leg Med; 2011 Jan; 32(1):115-28. PubMed ID: 21391059
    [No Abstract]   [Full Text] [Related]  

  • 10. Overcoming injustice: A roadmap to improve access to hepatitis C virus therapy for our medicaid patients.
    Carter LDB; Aronsohn A
    Hepatology; 2017 May; 65(5):1735-1740. PubMed ID: 28160311
    [No Abstract]   [Full Text] [Related]  

  • 11. Universal Medicine Access through Lump-Sum Remuneration - Australia's Approach to Hepatitis C.
    Moon S; Erickson E
    N Engl J Med; 2019 Feb; 380(7):607-610. PubMed ID: 30763190
    [No Abstract]   [Full Text] [Related]  

  • 12. Pfizer to make palbociclib temporarily free on NHS.
    Burki TK
    Lancet Oncol; 2017 Jun; 18(6):e309. PubMed ID: 28506556
    [No Abstract]   [Full Text] [Related]  

  • 13. New drug pricing scheme could politicise decisions and reduce access, says think tank.
    O'Dowd A
    BMJ; 2013 May; 346():f2965. PubMed ID: 23657194
    [No Abstract]   [Full Text] [Related]  

  • 14. China rejects patent on hepatitis C drug sofosbuvir.
    Kmietowicz Z
    BMJ; 2015 Jun; 350():h3429. PubMed ID: 26105994
    [No Abstract]   [Full Text] [Related]  

  • 15. Payers Sued Over Coverage Of Expensive Hepatitis C Drugs.
    Silverman E
    Manag Care; 2016 Apr; 25(4):9. PubMed ID: 27265961
    [No Abstract]   [Full Text] [Related]  

  • 16. NICE approval of new hepatitis drug could result in £700m bill for NHS.
    Hawkes N
    BMJ; 2015 Oct; 351():h5554. PubMed ID: 26491096
    [No Abstract]   [Full Text] [Related]  

  • 17. Betting on hepatitis C: how financial speculation in drug development influences access to medicines.
    Roy V; King L
    BMJ; 2016 Jul; 354():i3718. PubMed ID: 27815237
    [No Abstract]   [Full Text] [Related]  

  • 18. Fair global drug pricing.
    Campbell JD; Kaló Z
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):581-583. PubMed ID: 30215535
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals: pharmaceutical cost controls.
    Seay M; Lee LL
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-22. PubMed ID: 17357250
    [No Abstract]   [Full Text] [Related]  

  • 20. Wales approves new hepatitis C drug while England deliberates.
    Ozieranski P; King L
    BMJ; 2016 Dec; 355():i6499. PubMed ID: 27908876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.